passage bio stock news

PASG a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system dis. CASI Pharmaceuticals currently has a consensus price target of 300 indicating a potential upside of 77133.

Is Passage Bio Nasdaq Pasg In A Good Position To Invest In Growth

Common Stock PASG Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets.

. Comparatively CASI Pharmaceuticals has a beta of 066 suggesting that. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Passage Bio to Report Fourth Quarter and Full-Year 2021 Financial Results on March 3 2022.

24 2022 GLOBE NEWSWIRE -- Passage Bio Inc. PASG was reported by Goldman Sachs on January 19 2022. No significant news for PASG in the past two years.

According to data from MarketBeat Passage Bio presently has an average rating of Buy and a consensus price target of 1450. Get the latest Passage Bio Inc. View analysts price targets for Passage Bio or view top-rated stocks among Wall Street analysts.

The analyst firm set a price target for 600 expecting PASG to rise to within 12. Stock news by MarketWatch. Searching for Financial Security.

Ad Ensure Your Investments Align with Your Goals. PASG stock quote history news and other vital information to help you with your stock trading and investing. On average they anticipate Passage Bios stock price to reach 1700 in the next twelve months.

The stock has a 52-week low of 1210 and a 52-week high of 3087. Learn more about Passage Bio. PASG stock price quote stock graph news analysis.

06 2021 Passage Bio upgraded to buy from neutral at Goldman Sachs. Passage Bio files for common stock offering up to 125M and mixed shelf offering SA News Sat Mar. Find a Dedicated Financial Advisor Now.

Passage Bio Announces Maxine Gowen PhD as Chairwoman of the Board of Directors. What are analysts forecasts for Passage Bio stock. During the same quarter in the prior year the company posted 076 earnings per share.

In other Passage Bio news major shareholder Orbimed Advisors Llc acquired 221500 shares of the businesss stock in a transaction on Tuesday May 3rd. PASG Complete Passage Bio Inc. Our Financial Advisors Offer a Wealth of Knowledge.

At the time of publication shares of Passage Bio were trading 132 higher at 1499. The 13 analysts offering price forecasts for Passage Bio have a median target of 2462 with a high estimate of 4500 and a. A high-level overview of Passage Bio Inc.

News Passage Bio IncPASG. Find the latest Passage Bio Inc. PASG Passage Bio Inc Quarterly Report 10-q Indicate by check mark whether the registrant 1 has filed all reports required to be filed by Section 13 or 15d of the Securities Exchange Act of 1934 during the preceding 12 months or for such shorter period that the registrant was required to file such reports and 2 has been subject to such filing.

Please note that any opinions estimates or forecasts regarding Passage Bio Incs performance made by these analysts are theirs alone and do not represent opinions forecasts or predictions of Passage Bio. Passage Bio stock news alerts and headlines are usually related to their technical predictive social and fundamental indicators. As a group analysts expect that Passage Bio will post -316 earnings per share for the current year.

It can reflect on the current distribution of Passage daily returns and investor perception about the current pice of Passage Bio as well as its diversification or hedging effects on your existing portfolios. 12 hours agoVolatility and Risk. Passage Bio stock opened at 176 on Friday.

Passage Bio Stock Prediction. View real-time stock prices and stock quotes for a full financial overview. Their forecasts range from 600 to 3400.

Find the latest news headlines from Passage Bio Inc. Passage Bio has a beta of 185 suggesting that its stock price is 85 more volatile than the SP 500. 2 months ago - GlobeNewsWire.

PASG stock news and headlines to help you in your trading and investing decisions. Passage Bio names new board chair following sudden death of Dr. Is followed by the analysts listed above.

This suggests a possible upside of 8444 from the stocks current price. Get Passage Bio Inc PASGNASDAQ real-time stock quotes news price and financial information from CNBC. Real time Passage Bio Inc.

Passage Bio has a consensus price target of 1275 indicating a potential upside of. The latest price target for Passage Bio NASDAQ. Passage Bio has a.

Discover what drives us. The Price to Earnings PE ratio a key valuation measure is calculated by.

60ub 8vjrulynm